Genome-wide effects of the antimicrobial peptide apidaecin on translation termination in bacteria

Elife. 2020 Oct 8:9:e62655. doi: 10.7554/eLife.62655.

Abstract

Biochemical studies suggested that the antimicrobial peptide apidaecin (Api) inhibits protein synthesis by binding in the nascent peptide exit tunnel and trapping the release factor associated with a terminating ribosome. The mode of Api action in bacterial cells had remained unknown. Here genome-wide analysis reveals that in bacteria, Api arrests translating ribosomes at stop codons and causes pronounced queuing of the trailing ribosomes. By sequestering the available release factors, Api promotes pervasive stop codon bypass, leading to the expression of proteins with C-terminal extensions. Api-mediated translation arrest leads to the futile activation of the ribosome rescue systems. Understanding the unique mechanism of Api action in living cells may facilitate the development of new medicines and research tools for genome exploration.

Keywords: E. coli; PrAMPs; antibacterial peptides; antibiotics; biochemistry; chemical biology; rescue sysytems; ribosome; ribosome profiling.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Antimicrobial Cationic Peptides / pharmacology*
  • Codon, Terminator / drug effects
  • Codon, Terminator / metabolism*
  • Escherichia coli / drug effects*
  • Escherichia coli / metabolism
  • Genome, Bacterial / drug effects*
  • Peptide Chain Termination, Translational / drug effects*
  • Ribosomes / drug effects
  • Ribosomes / metabolism*

Substances

  • Antimicrobial Cationic Peptides
  • Codon, Terminator
  • apidaecin

Associated data

  • GEO/GSE150034